Copyright Reports & Markets. All rights reserved.

Global Endovascular Therapy Device Market Research Report 2021

Request for Sample of this report
Buy now

1 Endovascular Therapy Device Market Overview

  • 1.1 Product Overview and Scope of Endovascular Therapy Device
  • 1.2 Endovascular Therapy Device Segment by Type
    • 1.2.1 Global Endovascular Therapy Device Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Aortic Stents
    • 1.2.3 Biodegradable Stents
    • 1.2.4 Self-expanding Nitinol Stents
    • 1.2.5 Others
  • 1.3 Endovascular Therapy Device Segment by Application
    • 1.3.1 Endovascular Therapy Device Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinic
    • 1.3.4 Ambulatory Surgery Centre
  • 1.4 Global Endovascular Therapy Device Market Size Estimates and Forecasts
    • 1.4.1 Global Endovascular Therapy Device Revenue 2016-2027
    • 1.4.2 Global Endovascular Therapy Device Sales 2016-2027
    • 1.4.3 Endovascular Therapy Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Endovascular Therapy Device Market Competition by Manufacturers

  • 2.1 Global Endovascular Therapy Device Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Endovascular Therapy Device Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Endovascular Therapy Device Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Endovascular Therapy Device Manufacturing Sites, Area Served, Product Type
  • 2.5 Endovascular Therapy Device Market Competitive Situation and Trends
    • 2.5.1 Endovascular Therapy Device Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Endovascular Therapy Device Players Market Share by Revenue
    • 2.5.3 Global Endovascular Therapy Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Endovascular Therapy Device Retrospective Market Scenario by Region

  • 3.1 Global Endovascular Therapy Device Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Endovascular Therapy Device Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Endovascular Therapy Device Market Facts & Figures by Country
    • 3.3.1 North America Endovascular Therapy Device Sales by Country
    • 3.3.2 North America Endovascular Therapy Device Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Endovascular Therapy Device Market Facts & Figures by Country
    • 3.4.1 Europe Endovascular Therapy Device Sales by Country
    • 3.4.2 Europe Endovascular Therapy Device Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Endovascular Therapy Device Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Endovascular Therapy Device Sales by Region
    • 3.5.2 Asia Pacific Endovascular Therapy Device Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Endovascular Therapy Device Market Facts & Figures by Country
    • 3.6.1 Latin America Endovascular Therapy Device Sales by Country
    • 3.6.2 Latin America Endovascular Therapy Device Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Endovascular Therapy Device Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Endovascular Therapy Device Sales by Country
    • 3.7.2 Middle East and Africa Endovascular Therapy Device Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Endovascular Therapy Device Historic Market Analysis by Type

  • 4.1 Global Endovascular Therapy Device Sales Market Share by Type (2016-2021)
  • 4.2 Global Endovascular Therapy Device Revenue Market Share by Type (2016-2021)
  • 4.3 Global Endovascular Therapy Device Price by Type (2016-2021)

5 Global Endovascular Therapy Device Historic Market Analysis by Application

  • 5.1 Global Endovascular Therapy Device Sales Market Share by Application (2016-2021)
  • 5.2 Global Endovascular Therapy Device Revenue Market Share by Application (2016-2021)
  • 5.3 Global Endovascular Therapy Device Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Cardinal Health
    • 6.1.1 Cardinal Health Corporation Information
    • 6.1.2 Cardinal Health Description and Business Overview
    • 6.1.3 Cardinal Health Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Cardinal Health Product Portfolio
    • 6.1.5 Cardinal Health Recent Developments/Updates
  • 6.2 Lombard Medical Technologies
    • 6.2.1 Lombard Medical Technologies Corporation Information
    • 6.2.2 Lombard Medical Technologies Description and Business Overview
    • 6.2.3 Lombard Medical Technologies Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Lombard Medical Technologies Product Portfolio
    • 6.2.5 Lombard Medical Technologies Recent Developments/Updates
  • 6.3 Lifetech Scientific
    • 6.3.1 Lifetech Scientific Corporation Information
    • 6.3.2 Lifetech Scientific Description and Business Overview
    • 6.3.3 Lifetech Scientific Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Lifetech Scientific Product Portfolio
    • 6.3.5 Lifetech Scientific Recent Developments/Updates
  • 6.4 Boston Scientific
    • 6.4.1 Boston Scientific Corporation Information
    • 6.4.2 Boston Scientific Description and Business Overview
    • 6.4.3 Boston Scientific Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Boston Scientific Product Portfolio
    • 6.4.5 Boston Scientific Recent Developments/Updates
  • 6.5 Endospan
    • 6.5.1 Endospan Corporation Information
    • 6.5.2 Endospan Description and Business Overview
    • 6.5.3 Endospan Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Endospan Product Portfolio
    • 6.5.5 Endospan Recent Developments/Updates
  • 6.6 Getinge
    • 6.6.1 Getinge Corporation Information
    • 6.6.2 Getinge Description and Business Overview
    • 6.6.3 Getinge Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Getinge Product Portfolio
    • 6.6.5 Getinge Recent Developments/Updates
  • 6.7 InspireMD
    • 6.6.1 InspireMD Corporation Information
    • 6.6.2 InspireMD Description and Business Overview
    • 6.6.3 InspireMD Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 InspireMD Product Portfolio
    • 6.7.5 InspireMD Recent Developments/Updates
  • 6.8 Japan Lifeline
    • 6.8.1 Japan Lifeline Corporation Information
    • 6.8.2 Japan Lifeline Description and Business Overview
    • 6.8.3 Japan Lifeline Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Japan Lifeline Product Portfolio
    • 6.8.5 Japan Lifeline Recent Developments/Updates
  • 6.9 Endologix
    • 6.9.1 Endologix Corporation Information
    • 6.9.2 Endologix Description and Business Overview
    • 6.9.3 Endologix Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Endologix Product Portfolio
    • 6.9.5 Endologix Recent Developments/Updates
  • 6.10 Medtronic
    • 6.10.1 Medtronic Corporation Information
    • 6.10.2 Medtronic Description and Business Overview
    • 6.10.3 Medtronic Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Medtronic Product Portfolio
    • 6.10.5 Medtronic Recent Developments/Updates
  • 6.11 Penumbra
    • 6.11.1 Penumbra Corporation Information
    • 6.11.2 Penumbra Endovascular Therapy Device Description and Business Overview
    • 6.11.3 Penumbra Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Penumbra Product Portfolio
    • 6.11.5 Penumbra Recent Developments/Updates
  • 6.12 Terumo
    • 6.12.1 Terumo Corporation Information
    • 6.12.2 Terumo Endovascular Therapy Device Description and Business Overview
    • 6.12.3 Terumo Endovascular Therapy Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Terumo Product Portfolio
    • 6.12.5 Terumo Recent Developments/Updates

7 Endovascular Therapy Device Manufacturing Cost Analysis

  • 7.1 Endovascular Therapy Device Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Endovascular Therapy Device
  • 7.4 Endovascular Therapy Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Endovascular Therapy Device Distributors List
  • 8.3 Endovascular Therapy Device Customers

9 Endovascular Therapy Device Market Dynamics

  • 9.1 Endovascular Therapy Device Industry Trends
  • 9.2 Endovascular Therapy Device Growth Drivers
  • 9.3 Endovascular Therapy Device Market Challenges
  • 9.4 Endovascular Therapy Device Market Restraints

10 Global Market Forecast

  • 10.1 Endovascular Therapy Device Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Endovascular Therapy Device by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Endovascular Therapy Device by Type (2022-2027)
  • 10.2 Endovascular Therapy Device Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Endovascular Therapy Device by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Endovascular Therapy Device by Application (2022-2027)
  • 10.3 Endovascular Therapy Device Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Endovascular Therapy Device by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Endovascular Therapy Device by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Aortic Stents
    Biodegradable Stents
    Self-expanding Nitinol Stents
    Others

    Segment by Application
    Hospitals
    Clinic
    Ambulatory Surgery Centre

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Cardinal Health
    Lombard Medical Technologies
    Lifetech Scientific
    Boston Scientific
    Endospan
    Getinge
    InspireMD
    Japan Lifeline
    Endologix
    Medtronic
    Penumbra
    Terumo

    Buy now